Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Other Accumulated Expenses: 2015-2025

Historic Other Accumulated Expenses for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2025 value amounting to $5.1 million.

  • HUTCHMED (China)'s Other Accumulated Expenses fell 15.45% to $5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year decrease of 15.45%. This contributed to the annual value of $12.5 million for FY2024, which is 19.09% up from last year.
  • As of Q2 2025, HUTCHMED (China)'s Other Accumulated Expenses stood at $5.1 million, which was down 58.99% from $12.5 million recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Other Accumulated Expenses ranged from a high of $37.2 million in Q2 2022 and a low of $5.1 million during Q2 2025.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $6.8 million (2023), whereas its average is $8.2 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first soared by 443.17% in 2022, then crashed by 81.71% in 2023.
  • Quarterly analysis of 5 years shows HUTCHMED (China)'s Other Accumulated Expenses stood at $17.2 million in 2021, then dropped by 28.97% to $12.2 million in 2022, then declined by 14.20% to $10.5 million in 2023, then rose by 19.09% to $12.5 million in 2024, then dropped by 15.45% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q2 2025, $12.5 million for Q4 2024, and $6.1 million during Q2 2024.